Clinical Trial

Hydroxychloroquine in Mild Graves' Orbitopathy

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is aimed to investigate the effect of hydroxychloroquine in patients with mild Graves' orbitopathy (GO).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-16; most recent amendment 2025-02-23.
Status change: Not Yet Recruiting → Recruiting 2022-12-01
Trial Details
NCT Number NCT05126147
Lead Sponsor National Taiwan University Hospital
Conditions Graves Ophthalmopathy
Enrollment 108 participants
Start Date 2022-03-21
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-25